BRA
ZBH icon

Biechele Royce Advisors’s Zimmer Biomet ZBH Stock Holding History

Biechele Royce Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.14M Buy
66,110
+11,496
+21% +$1.25M 2.35% 16
2024
Q2 		$5.93M Sell
54,614
-1,306
-2% -$154K 2% 20
2024
Q1 		$7.38M Sell
55,920
-1,100
-2% -$137K 2.45% 17
2023
Q4 		$6.94M Buy
57,020
+4,484
+9% +$500K 2.27% 18
2023
Q3 		$5.9M Sell
52,536
-587
-1% -$74.5K 2.17% 19
2023
Q2 		$7.74M Buy
53,123
+764
+1% +$104K 2.69% 17
2023
Q1 		$6.76M Buy
52,359
+4,347
+9% +$546K 2.52% 18
2022
Q4 		$6.12M Buy
48,012
+11,046
+30% +$1.28M 2.5% 17
2022
Q3 		$3.86M Buy
36,966
+1,614
+5% +$177K 1.82% 22
2022
Q2 		$3.71M Buy
35,352
+6,257
+22% +$742K 1.65% 23
2022
Q1 		$3.72M Buy
29,095
+10,834
+59% +$1.31M 1.48% 24
2021
Q4 		$2.25M Buy
18,261
+4,683
+34% +$613K 0.9% 26
2021
Q3 		$1.93M Sell
13,578
-21
-0.2% -$3.09K 0.85% 26
2021
Q2 		$2.12M Buy
13,599
+424
+3% +$68.7K 0.92% 27
2021
Q1 		$2.05M Sell
13,175
-327
-2% -$50.7K 1.03% 24
2020
Q4 		$2.02M Sell
13,502
-532
-4% -$75.1K 1.14% 24
2020
Q3 		$1.85M Sell
14,034
-1,322
-9% -$173K 1.17% 25
2020
Q2 		$1.78M Sell
15,356
-2,622
-15% -$302K 1.12% 25
2020
Q1 		$1.76M Sell
17,978
-8,071
-31% -$1.06M 1.36% 25
2019
Q4 		$3.79M Sell
26,049
-1,951
-7% -$269K 2.28% 21
2019
Q3 		$3.73M Sell
28,000
-6,194
-18% -$800K 2.47% 21
2019
Q2 		$3.91M Sell
34,194
-669
-2% -$78.4K 2.58% 17
2019
Q1 		$4.32M Sell
34,863
-9,672
-22% -$1.1M 2.8% 17
2018
Q4 		$4.49M Sell
44,535
-1,566
-3% -$176K 3.23% 14
2018
Q3 		$5.88M Buy
46,101
+1,677
+4% +$199K 3.68% 11
2018
Q2 		$4.7M Hold
44,424
– – 3.15% 14
2018
Q1 		$4.7M Buy
44,424
+20
+0% +$2.32K 3.28% 12
2017
Q4 		$5.2M Buy
+44,404
New +$5.02M 3.54% 11

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Biechele Royce Advisors's ZBH Position: Q3 2024 in Review

Biechele Royce Advisors increased its Zimmer Biomet (ZBH) stake by 21% in Q3 2024, buying an estimated $1.25M and bringing the position to 66,110 shares worth $7.14M. The position accounts for 2.35% of the portfolio, ranked #16.

Biechele Royce Advisors first reported a position in ZBH in Q4 2017 and has held it in 28 quarters since. The position peaked at $7.74M in Q2 2023. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Biechele Royce Advisors held 66,110 shares of Zimmer Biomet worth $7.14M as of Q3 2024.
  • Biechele Royce Advisors bought 11,496 Zimmer Biomet shares in Q3 2024, an estimated $1.25M.
  • Zimmer Biomet made up 2.35% of Biechele Royce Advisors's portfolio in Q3 2024, its #16 holding.
  • Biechele Royce Advisors first reported a position in Zimmer Biomet in Q4 2017 and has held it in 28 quarters since.
  • Biechele Royce Advisors's Zimmer Biomet position peaked at $7.74M in Q2 2023.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Biechele Royce Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.